Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-708-6 | CAS number: 688-84-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Data availability
For 2-EHMA the entire set of screening studies is available, including two gene mutation assays in bacteria, two chromosome mutation assays in hamster cells and human lymphocytes and a gene mutation test in mammalian cells. Therefore, further testing in vivo is not required.
In vitro gene mutation assay on bacteria
A Salmonella typhimurium reverse mutation assay was performed with 2-ethylhexyl methacrylate according to OECD Guideline 471 and GLP (Molinier, 1994). S. typhimurium strains, TA98, TA100, TA102, TA1535 and TA1537 were exposed to five concentrations of 2-ethylhexyl methacrylate in the presence and absence of a metabolic activation system using the plate incorporation and the preincubation methods. All doses of 2-ethylhexyl methacrylate, vehicle control and positive controls were plated in triplicate and incubated for 48-72 hours at 37°C. The positive controls gave expected responses. 2-ethylhexyl methacrylate was cytotoxic at >= 100 µg/plate without S9, >= 5000 µg/plate with S9 (plate incorporation assay) and >= 250 µg/plate (preincubation assay). Treatment of the S. Typhimurium strains with 2-ethylhexyl methacrylate in the presence or absence of metabolic activation did not induce any significant increases in the revertant numbers.
A second, equally valid bacterial mutation assay in S. Typhimurium strains, TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2 uvr A according to OECD 471/472 also produced a negative result (Miyagawa et al., 1998). In this study the range of tested concentrations was between 10 and 5000 µg/plate without and with metabolic activation by benzoflavone/phenobarbital induced S9 using both, the plate incorporation and the preincubation protocol.
In vitro chromosomal aberration assay on mammalian cells
In an OECD guideline 473and GLP in vitro cytogenetics assay, 2-Ethylhexyl methacrylate was tested using duplicate human lymphocyte cultures from a male human donor (1997). Treatments covering a broad range of doses, separated by narrow intervals, were performed both in the absence and presence of metabolic activation by a rat liver post-mitochondrial fraction (S-9) from Aroclor 1254 induced animals. The highest dose level used, 1980 µg/mL was equivalent to a 10 mM concentration and exceeded the limit of solubility. Appropriate negative (solvent) control cultures and untreated cultures were included in the test system under each treatment condition. The proportion of cells with structural aberrations in negative control cultures fell within historical solvent control ranges. Untreated cultures were not analysed. 4-Nitroquinoline 1-oxide and cyclophosphamide were employed as positive control chemicals in the absence and presence of liver S-9 respectively and both compounds induced statistically significant increases in the proportion of cells with structural aberrations.
Treatment of cultures with 2-ethylhexyl methacrylate in the absence of S-9 resulted in frequencies of cells with aberrations which were similar to and not significantly different from those seen in concurrent negative control ranges. Numbers of cells with aberrations in all treated cultures fell within the historical negative control (normal) range at both sampling times.
Treatment of cultures with 2-ethylhexyl methacrylate in the presence of S-9 resulted in frequencies of cells with aberrations which were significantly higher than those in concurrent controls. Numbers of aberrant cells, however, exceeded the normal range in only a single replicate at the highest dose level at each sampling time. Insofar as increases at this concentration were very small and not reproduced in both replicates the observation was not considered biologically significant.
A second, equally valid assay in Chinese hamster lung (CHL/IU) cells was also reported with a negative result (Ohta et al., 1998). The CHL cells were tested at concentrations in a range of 10 to 5000 µg/ml without and with metabolic activation by benzoflavone/phenobarbital induced S9. No increase in structural or numerical aberrations was reported.
It is concluded that 2-Ethylhexyl methacrylate did not induce chromosome aberrations in cultured human peripheral blood lymphocytes and Chinese hamster lung cells when tested to its limit of toxicity in both the absence and presence of S-9.
In vitro gene mutation assay on mammalian cells
The potential of 2-Ethylhexyl methacrylate to induce gene mutations at the HPRT locus in V79 tells of the Chinese hamster was investigated in an OECD guideline 476 and GLP study (Harlan, 2008). The assay was performed in two independent experiments. The cells were exposed to the test item for 4 hours in the first experiment with and without metabolic activation. The second experiment was performed with a treatment period of 24 hours in the absence and 4 hours in the presence of metabolic activation. The maximum dose of the pre-test was 2000 µg/mL corresponding to a molar concentration of about 10 mM. The concentration range of the main experiments was limited by cytotoxic effects and was 0.1 - 16.0 (1stexperiment) and 3.8 – 60.0 (2ndexperiment) µg/ml without S9 and 62.5 – 2000 µg/ml with S9 (1stand 2ndexperiments). No substantial and reproducible dose dependent increase of the mutation frequency was observed in the main experiments up to the maximum concentration. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies and thus showed the sensitivity of the test system and the activity of the S9 mix. In conclusion, 2-ethylhexyl methacrylate did not induce gene mutations et the HPRT locus in V79 cells.
Summary
EHMA does have a full set of standard mutagenicity screening tests. It is negative in the bacterial gene mutation test, as well as in gene mutation and chromosome mutation tests in mammalian cells. In summary, 2-EHMA is regarded as non-mutagenic.
Short description of key information:
2-ethylhexyl methacrylate is not genotoxic in in vitro gene mutation
assays in bacteria (Ames test) and mammalian cells (HGPRT assay) and in
an in vitro chromosomal aberration assay in human lymphocytes and
Chinese hamster lung cells.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
According to the available negative in vitro assays and CLP criteria, no classification is warranted for germ cell mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.